ESMO 2025: OncoDaily Coverage

asdfs

OncoDaily Grand Rounds: GI Edition during ESMO 2025, Berlin

OncoDaily Grand Rounds: GI Edition during ESMO 2025, Berlin

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

Garo Armen: FDA Must Keep Up With Science

FDA

Rob Winn: Americans Overwhelmingly Support Strong Federal Investment in Cancer Research

Rob Winn

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Mexico Targets Late Diagnoses With Yearly Mammograms From 40

Mexico

ESO and EONS Launch Fellowship Programme for Cancer Nurses Across Europe

ESO and EONS Launch Fellowship Programme for Cancer Nurses Across Europe

ON-COLLAB Brazil - International Workshop on Oncology Research Methods

ON-COLLAB

OncoCalendar

« All Events

  • This event has passed.

Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR

Jan 21 • 1:00 PM - 2:30 PM
AACR

Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR will be held on January 21, 2025, Virtually.

The forum will explore the new generation of patient-centric cancer clinical trials, focusing on how advancements in cancer research will reshape the clinical trial process. As more people are expected to survive and live beyond cancer, largely due to clinical trials, the conference will highlight the ongoing transformation in trial design. The emphasis will be on creating more efficient, inclusive, and patient-focused trials that prioritize patient needs and preferences. This shift will be critical in ensuring broader access to innovative treatments and improving overall patient outcomes.

The upcoming session will feature a group of esteemed experts in the field of cancer research. Jan Tomlinson from the University of California, San Francisco, will share insights from a patient advocate’s perspective on the clinical trial experience. Patricia M. LoRusso, DO, PhD (HC), FAACR, from Yale Cancer Center, will discuss innovative clinical trial designs aimed at improving efficiency and inclusivity. David A. Tuveson, MD, PhD, FAACR, from CSHL Cancer Center, will highlight the Cancer Therapeutics Initiative, which focuses on translating basic research into clinical applications. Laura van ‘t Veer, PhD, from the University of California, San Francisco, will present on the second-generation design of the I-SPY 2 trial, driving advancements in precision medicine. These experts will cover a broad range of topics, all geared toward advancing cancer clinical trials and patient care.

Register Now!

Details

Date:
Jan 21
Time:
1:00 PM - 2:30 PM
Website:
https://www.aacr.org/patients-caregivers/patient-advocacy/aacr-events-for-patient-advocates/aacr-virtual-patient-advocate-forums/exploring-a-new-generation-of-patient-centric-cancer-clinical-trials/

Organizer

American Association for Cancer Research
Phone
215-440-9300
Email
aacr@aacr.org
View Organizer Website